Maximilian Joos

University Hospital Heidelberg

Papers

1

Total Citations

118

H-Index

1

About

Maximilian Joos is a leading surgical oncologist whose research centers on advancing minimally invasive techniques for complex pancreatic surgery, with a particular focus on robotic-assisted procedures. His most impactful contribution is the landmark EUROPA trial, a randomised controlled stage 2b study comparing robotic versus open partial pancreatoduodenectomy—one of the most demanding abdominal operations. Published in 2024 and already garnering 118 citations, this work provides critical evidence on the safety and feasibility of robotic approaches for pancreatic head resections, challenging the traditional gold standard of open surgery, which carries morbidity rates around 40%. Joos’s research directly addresses the pressing need to reduce postoperative complications while expanding access to minimally invasive options. Beyond this trial, his work has helped define best practices in hepatopancreatobiliary surgery, influencing both clinical guidelines and surgical training. By rigorously evaluating robotic techniques through high-quality randomised evidence, Joos is shaping the future of pancreatic cancer care, offering patients potentially faster recovery with fewer complications. His contributions are essential reading for surgeons and researchers working to improve outcomes in one of surgery’s most challenging fields.

Research Focus

Key Achievements

1
H-Index
1
Papers
118
Total Citations
118
Avg Citations/Paper
🏆 Most Cited Paper
Robotic versus open partial pancreatoduodenectomy (EUROPA): a randomised controlled stage 2b trial
118 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: University Hospital Heidelberg

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago